MedDataX Logo

Personality Characteristics and Compliance With Antiglaucoma Medication

NCT ID: NCT00481494

Last Updated: 2007-06-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-05-31

Study Completion Date

2007-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Personality traits may influence to the drug compliance in glaucoma patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In chronic diseases, especially asymptomatic at early stage, drug compliance has been reported as an important factor to control them. And personality traits are associated with the drug compliance. However, there was few study to consider this relationship. We want to find the association the personality characteristics and drug compliance in glaucoma patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic glaucoma
* Topical anti-glaucoma medications

Exclusion Criteria

* Oral glaucoma medications
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chan Yun Kim, MD, PhD

Role: STUDY_CHAIR

Department of Ophthalmology, Yonsei University College of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Severance Hospital, Yonsei University College of Medicine

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chan Yun Kim, MD, PhD

Role: CONTACT

[email protected]
82-2-2228-3580

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Chan Yun Kim, MD, PhD

Role: primary

[email protected]
82-2-2228-3580

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4-2007-0092

Identifier Type: -

Identifier Source: org_study_id